The trademark application ADBRY was filed by LEO Pharma A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on July 14, 2021, and it was registered by office on October 21, 2021 without any oppositions.
The application was filed in Danish (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on May 1, 2022.